Daiichi Sankyo

Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Forbes
Thu, 12/5/13 - 06:45 pm
bloodthinners
Pradaxa
Boehringer Ingelheim
Xarelto
JNJ
Eliquis
Pfizer
Bristol-Myers Squibb
edoxaban
Daiichi Sankyo
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Seeking Alpha
Thu, 12/5/13 - 06:43 pm
Pfizer
GSK
melanoma
Bristol-Myers Squibb
AstraZeneca
Daiichi Sankyo
Novartis
Yervoy
palbociclib
Mekinist
Zelboraf
New Anticoagulant From Daiichi Sankyo Works Well In AF Patients
Forbes
Tue, 11/19/13 - 12:35 pm
Daiichi Sankyo
edoxaban
bloodthinners
Warfarin
atrial fibrillation
Can The First Malaria Vaccine Drive GlaxoSmithKline's Growth?
Seeking Alpha
Wed, 10/16/13 - 08:35 am
GSK
vaccines
malaria
Agenus
Daiichi Sankyo
RTS,S
JNJ
Data on ArQule's Tivantinib
Yahoo/Zacks
Sat, 10/5/13 - 09:18 am
Arqule
tivantinib
Daiichi Sankyo
lung cancer
non-small cell lung cancer
ArQule up on hope for lung cancer drug revival
Reuters
Fri, 09/27/13 - 11:51 am
Arqule
tivantinib
Daiichi Sankyo
lung cancer
Daiichi Sankyo’s New Blood Thinner Matched Warfarin in Study
Bloomberg
Tue, 09/3/13 - 09:27 am
bloodthinners
Daiichi Sankyo
Warfarin
edoxaban
Astellas forecasts big sales growth as prostate drug catches hold
Fierce Pharma
Mon, 05/13/13 - 12:27 pm
Astellas
Xtandi
Daiichi Sankyo
Japan
Takeda
prostate cancer
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Yahoo
Mon, 04/1/13 - 10:58 am
ARQ092
Daiichi Sankyo
Arqule
akt protein inhibitor
cancer
Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance
Seeking Alpha
Tue, 01/15/13 - 11:39 am
tivantinib
Arqule
colorectal cancer
Daiichi Sankyo
ArQule: An Inexpensive And Well-Financed Oncology Opportunity
Seeking Alpha
Thu, 12/13/12 - 04:29 pm
Arqule
Daiichi Sankyo
ARQ-087
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tue, 10/2/12 - 11:25 am
Arqule
lung cancer
Daiichi Sankyo
tivantinib
non-small cell lung cancer
Lilly heart drug Effient fails to carve new niche
Reuters
Sun, 08/26/12 - 11:04 am
Eli Lilly
Effient
Plavix
Daiichi Sankyo
Sanofi
antiplatelet therapy
Bristol-Myers Squibb
TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients
Forbes
Sun, 08/26/12 - 11:02 am
Sanofi
Prasugrel
Plavix
Effient
Daiichi Sankyo
Clopidogrel
antiplatelet therapy
Eli Lilly
China Biotech In Review: Fidelity Starts New VC Fund For China Healthcare
Seeking Alpha
Sun, 04/22/12 - 01:28 pm
Fidelity Investments
Daiichi Sankyo
Shanghai Xinshengyuan
Luqa Pharma
Ebernet
Cyclacel: An Intriguing Long Shot
Seeking Alpha
Tue, 03/20/12 - 10:35 am
Cyclacel
Sapacitabine
cancer
Daiichi Sankyo
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Seattle Genetics
Celldex
Arqule
Daiichi Sankyo
JNJ
Medivation
Dendreon
Aveo Pharmaceutical
Ariad Pharmaceuticals
AstraZeneca
Array Biopharma
Oncothyreon
Daiichi Sankyo, GlaxoSmithKline Form Vaccine Venture
WSJ Online
Mon, 03/5/12 - 11:03 am
GSK
vaccines
Daiichi Sankyo
Japan
ArQule license deal with Daiichi could land $265M
Bizjournals.com
Thu, 11/10/11 - 01:09 pm
Arqule
Daiichi Sankyo
kinase inhibitors
Daiichi Sankyo Cuts Full-Year Sales Forecast on Stronger Yen
Bloomberg
Mon, 10/31/11 - 12:00 pm
earnings
Daiichi Sankyo

Pages